In a June 25 vote, the National Quality Forum (NQF) board of directors upheld a previous decision to endorse an all-cause hospitalwide readmission measure that was developed by both the Centers for Medicare & Medicaid Services (CMS) and Yale University.

Siemens Healthcare has launched the Acuson P300 ultrasound system, a compact portable device designed for various clinical disciplines, including radiology and general imaging, cardiovascular imaging, obstetrics and gynecology and specialty imaging.

The detection of kidney stones using extremely low-dose CT is more difficult in obese patients, but new research has shown that the sensitivity and specificity for the detection of ureteral calculi on CT is decreased for underweight patients as well, according to a study published in the July issue of the Journal of Urology.

GE is pouring $7.5 million into an Australian company, Nanosonics, to push along the latters development and distribution of a disinfecting system for ultrasound transducers called Trophon EPR.

The FDA has issued a complete response letter regarding Janssen Research & Development's supplemental New Drug Application for rivaroxaban (Xarelto) for the reduction of the risk of secondary cardiovascular events in patients with acute coronary syndrome (ACS). Janssen said it is evaluating the complete response letter and will respond to the agency's questions.

Carestream Health in Rochester, N.Y., has started shipping its DRX-Revolution mobile x-ray system.

GE Healthcare unveiled a program for low-dose CT imaging called GE Blueprint during an announcement June 21 at North Shore Long Island Jewish Health System.

Ultrasonography has been shown to be a useful tool for evaluating and treating adult sepsis patients in the emergency department, with physicians altering initial management plans based on point-of-care ultrasonographic data in more than 50 percent of cases, according to a study published online May 28 in the Annals of Emergency Medicine.